Proteomic screening for novel therapeutic targets in kidney diseases
The high-throughput capability of proteomics allows simultaneous examination of numerous proteins and makes a global analysis of proteins in cell, tissue, organ or biofluid possible. This strength of proteomics has been extensively applied to examine altered proteins caused by various diseases. Some...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/23067 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.23067 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.230672018-08-20T14:25:12Z Proteomic screening for novel therapeutic targets in kidney diseases Visith Thongboonkerd Mahidol University Biochemistry, Genetics and Molecular Biology Pharmacology, Toxicology and Pharmaceutics The high-throughput capability of proteomics allows simultaneous examination of numerous proteins and makes a global analysis of proteins in cell, tissue, organ or biofluid possible. This strength of proteomics has been extensively applied to examine altered proteins caused by various diseases. Some of these altered proteins may particularly be important for the disease progression and/or complications. Thus, information on these altered proteins is valuable for better understanding of the pathogenesis and pathophysiology of medical diseases. Additionally, functional analysis of such proteins may lead to identification of novel therapeutic targets and development of new drugs for improving therapeutic outcome as well as for preventing serious complications. This review focuses mainly on applications of renal and urinary proteomics to define novel therapeutic targets in kidney diseases. Several recent studies on various kidney diseases have successfully identified altered renal and urinary proteins, some of which may potentially be the novel therapeutic targets. Urinary proteome profiling has also been applied to biomarker discovery that will be useful for clinical diagnostics, prognosis, prediction of treatment response, and development of personalized medicine. Finally, potential roles of proteomics for drug design and discovery are discussed. All rights reserved - © 2006 Bentham Science Publishers. 2018-08-20T06:52:27Z 2018-08-20T06:52:27Z 2006-03-01 Review Frontiers in Drug Design and Discovery. Vol.2, No.1 (2006), 87-102 15672042 2-s2.0-39849084928 https://repository.li.mahidol.ac.th/handle/123456789/23067 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=39849084928&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Biochemistry, Genetics and Molecular Biology Pharmacology, Toxicology and Pharmaceutics |
spellingShingle |
Biochemistry, Genetics and Molecular Biology Pharmacology, Toxicology and Pharmaceutics Visith Thongboonkerd Proteomic screening for novel therapeutic targets in kidney diseases |
description |
The high-throughput capability of proteomics allows simultaneous examination of numerous proteins and makes a global analysis of proteins in cell, tissue, organ or biofluid possible. This strength of proteomics has been extensively applied to examine altered proteins caused by various diseases. Some of these altered proteins may particularly be important for the disease progression and/or complications. Thus, information on these altered proteins is valuable for better understanding of the pathogenesis and pathophysiology of medical diseases. Additionally, functional analysis of such proteins may lead to identification of novel therapeutic targets and development of new drugs for improving therapeutic outcome as well as for preventing serious complications. This review focuses mainly on applications of renal and urinary proteomics to define novel therapeutic targets in kidney diseases. Several recent studies on various kidney diseases have successfully identified altered renal and urinary proteins, some of which may potentially be the novel therapeutic targets. Urinary proteome profiling has also been applied to biomarker discovery that will be useful for clinical diagnostics, prognosis, prediction of treatment response, and development of personalized medicine. Finally, potential roles of proteomics for drug design and discovery are discussed. All rights reserved - © 2006 Bentham Science Publishers. |
author2 |
Mahidol University |
author_facet |
Mahidol University Visith Thongboonkerd |
format |
Review |
author |
Visith Thongboonkerd |
author_sort |
Visith Thongboonkerd |
title |
Proteomic screening for novel therapeutic targets in kidney diseases |
title_short |
Proteomic screening for novel therapeutic targets in kidney diseases |
title_full |
Proteomic screening for novel therapeutic targets in kidney diseases |
title_fullStr |
Proteomic screening for novel therapeutic targets in kidney diseases |
title_full_unstemmed |
Proteomic screening for novel therapeutic targets in kidney diseases |
title_sort |
proteomic screening for novel therapeutic targets in kidney diseases |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/23067 |
_version_ |
1763497172774420480 |